Keeping Current

Testing and Timing for COVID-19 Therapies: Understanding Factors for Optimization

Nov 29, 2023

Do you know the optimal time to start antiviral therapy for COVID-19?

Credit available for this activity expires: 11/29/24
Earn Credit / Learning Objectives & Disclosures:

Evolving Paradigms of Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates

Nov 27, 2023

Are you up to date on the latest clinical trial data on antibody-drug conjugates (ADCs) in hormone receptor (HR)-positive advanced breast cancer?

Credit available for this activity expires: 11/20/23
Earn Credit / Learning Objectives & Disclosures:

Early-Stage Resectable NSCLC: A Shifting Landscape With Targeted Therapies and Immunotherapy

Nov 23, 2023

The perioperative therapeutic landscape for early-stage resectable NSCLC is advancing rapidly. Are you up to date?

Credit available for this activity expires: 22/11/24
Earn Credit / Learning Objectives & Disclosures:

Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Multidisciplinary Perspectives on Managing and Maximizing Care

Nov 16, 2023

Do you know how adverse events (AEs) associated with Bruton tyrosine kinase (BTK) inhibitors affect patients’ lives and how best to manage these events?

Credit available for this activity expires: 11/15/24
Earn Credit / Learning Objectives & Disclosures:

Diabetes Dialogue: Can We Reduce the Disease Burden with Weekly Basal Insulin?

Nov 14, 2023

Did you know that adding basal insulin to patients who remain above target despite an optimal guideline-recommended antidiabetes regimen can further reduce HbA1c levels by up to 3 percentage points?

Credit available for this activity expires: 11/14/24
Earn Credit / Learning Objectives & Disclosures: